IRIS
ALUNNO, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.516
EU - Europa 752
AS - Asia 493
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
AF - Africa 1
Totale 2.788
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.510
IE - Irlanda 274
CN - Cina 192
SG - Singapore 157
TR - Turchia 123
SE - Svezia 99
DE - Germania 93
UA - Ucraina 85
IT - Italia 69
GB - Regno Unito 44
FI - Finlandia 30
FR - Francia 21
BR - Brasile 16
BE - Belgio 10
NL - Olanda 8
IN - India 7
VN - Vietnam 5
AU - Australia 4
EU - Europa 4
CA - Canada 3
CH - Svizzera 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
JP - Giappone 2
PK - Pakistan 2
RU - Federazione Russa 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
CO - Colombia 1
CR - Costa Rica 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
HN - Honduras 1
IM - Isola di Man 1
JO - Giordania 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
PL - Polonia 1
PR - Porto Rico 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 2.788
Salva come PNG Salva come JPEG
Città #
Jacksonville 326
Chandler 315
Dublin 266
Singapore 121
Santa Clara 114
Boardman 102
Izmir 78
Nanjing 53
Wilmington 53
New York 51
Lawrence 48
Princeton 48
San Mateo 34
Beijing 30
Ashburn 28
Ann Arbor 27
L'aquila 22
Nanchang 20
Los Angeles 16
Pescara 15
Seattle 15
Dearborn 14
Des Moines 14
Milan 14
Shanghai 11
Woodbridge 11
Verona 10
Jiaxing 9
Norwalk 9
Tianjin 9
Dallas 8
Hebei 7
Mountain View 7
Munich 7
Brussels 6
Helsinki 6
Philadelphia 6
Pune 5
Zhengzhou 5
Berlin 4
Bremen 4
Changsha 4
Dong Ket 4
Frankfurt am Main 4
Hangzhou 4
Leuven 4
Ningbo 4
Shenyang 4
Amsterdam 3
Cedar Knolls 3
Falls Church 3
Forest City 3
Jinan 3
Jinhua 3
Kunming 3
Rome 3
Belo Horizonte 2
Brno 2
Englewood 2
Fremont 2
Grafing 2
Paris 2
Redwood City 2
Sydney 2
São Paulo 2
Alvorada 1
Amman 1
Arlington 1
Athens 1
Baku 1
Bangkok 1
Barbacena 1
Bournemouth 1
Bratislava 1
Brindisi 1
Brisbane 1
Brumado 1
Caruaru 1
Central District 1
Columbus 1
Conselheiro Lafaiete 1
Copenhagen 1
Custódia 1
Douglas 1
Düsseldorf 1
Edinburgh 1
Guanhães 1
Hefei 1
Illawong 1
Islamabad 1
Itabirito 1
Johannesburg 1
Karachi 1
Kitzingen 1
Kocaeli 1
Lanzhou 1
Lappeenranta 1
Lomas de Zamora 1
Londrina 1
Luxembourg 1
Totale 2.053
Salva come PNG Salva come JPEG
Nome #
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study 90
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 83
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 80
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 78
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 78
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 77
Unmasking the pathogenic role of il-17 axis in primary sj¨ogren’s syndrome: A new era for therapeutic targeting? 75
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 73
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 72
Common Features in Lymphoproliferative Complications in the Course of Primary Sjo‥gren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients 71
CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement. 68
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? 67
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 67
Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren’s syndrome: retrospective study in a large italian cohort 65
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis 65
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 65
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 62
Diet in rheumatoid arthritis versus systemic lupus erythematosus: Any differences? 62
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. 61
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 61
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome 60
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 57
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 55
Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome 54
The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans. 53
PREVALENCE AND PREDICTIVE ROLE OF TRADITIONAL CARDIOVASCULAR RISK FACTORS IN A COHORT OF SJÖGREN'S SYNDROME PATIENTS 52
Rituximab in primary Sjögren's syndrome: a ten-year journey 52
EFFICACY AND SAFETY OF RITUXIMAB ORIGINATOR AND BIOSIMILAR IN PRIMARY SJOGREN'S SYNDROME IN A REAL-LIFE SETTING 52
Characteristics of primary sjögren’s syndrome (PSS) patients with cryoglobulinemia in a large cohort of patients, and differences between hypergammaglobulinemic and cryoglobulinemic vasculitis in PSS 51
Adherence to the Mediterranean diet and the impact on clinical features in primary Sjögren's syndrome 51
IL-17 PRODUCING DOUBLE NEGATIVE (DN) T CELL PHENOTYPE AND FUNCTION IN PRIMARY SJÖGREN'S SYNDROME 49
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 49
12-MONTH OUTCOMES IN OVERWEIGHT/OBESE USERS WITH MENTAL DISORDERS FOLLOWING A MULTI-ELEMENT TREATMENT INCLUDING DIET, PHYSICAL ACTIVITY, AND POSITIVE THINKING: THE REAL-WORLD ‘AN APPLE A DAY’ CONTROLLED TRIAL 47
Histopathology of salivary glands 47
CLINICAL AND IMAGING FEATURES OF ARTICULAR MANIFESTATIONS IN PRIMARY SJOGREN'S SYNDROME: SIMILARITIES AND DIFFERENCES ACCORDING TO THE TIME OF ONSET 47
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 46
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units 45
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 44
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 44
The impact of fibromyalgia in spondyloarthritis: From classification criteria to outcome measures 42
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis 41
Thymic Stromal Lymphopoietin (TSLP) as a Biomarker of Primary Sjogren's Syndrome (pSS) and Related Lymphoma: Results in Independent Cohorts 40
THU0681 Baseline ESSDAI/DAS scores in 8061 patients with primary sjÖgren syndrome: characterization of systemic disease 40
The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren's syndrome 38
OP0044 Antibodies anti-saccharomyces cerevisiae in primary sjÖgren's syndrome: prevalence, clinical associations and possible cross-reactivity with disease specific autoantigens 38
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 34
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome 30
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 29
The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren’s Syndrome: Is Uric Acid the Missing Link? 25
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares 24
Neurological Involvement in a Cohort of Primary Sjogren's Syndrome Patients: Results of a Multicenter Italian Study 22
The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience 17
Electrocardiographic Abnormalities in Hospitalized Patients with COVID-19 and the Associations with Clinical Outcome 16
Different clinical presentations of primary Sjögren's syndrome: Not only a matter of age. Comment on: “Elderly-onset primary Sjögren's syndrome focused on clinical and salivary gland ultrasonographic features by Lee et al. Joint Bone Spine. 2021;88:105132” 14
SpA plus IBD or IBD plus SpA: Does commutative property apply? 13
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 13
Totale 2.851
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.617
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020225 0 0 0 0 0 39 43 14 53 18 5 53
2020/2021347 2 42 0 44 47 14 46 0 54 14 69 15
2021/2022263 10 11 38 24 8 10 2 15 24 8 24 89
2022/2023810 69 44 17 89 86 96 0 46 318 8 29 8
2023/2024232 23 13 11 18 24 80 1 13 1 14 5 29
2024/2025422 38 20 99 62 104 99 0 0 0 0 0 0
Totale 2.851